식물기반 치료용 항체생산
Plant-based production of therapeutic antibodies
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Antibodies are powerful and versatile tools to play a critical role in the diagnosis and treatment of many diseases. Their application has been enhanced significantly with the advanced recombinant DNA and heterologonous expression technologies, allowing to produce munotherapeutic proteins with improved biofunctional properties. However, with currently available technologies, mammalian cell-based therapeutic antibody production, as an alternative for production in humans and animals, is often not plentiful for passive immunotherapeutics in treatment of many diseases. Recently, plant expression systems for therapeutic antibodies have become well-established. Thus, plants have been considered to provide an attractive alternative production system for therapeutic antibodies, as plants have several advantages such as the lack of human pathogens, and low cost of upstream production and flexible scale-up of highly valuable recombinant glycoproteins. Recent advances in modification of posttranslational processing for human-like glycosylation in transgenic plants will make it possible that plant can become a suitable protein expression system over the animal cellbased current production system. This review will discuss recent advances in plant expression technology and issues for their application to therapeutic antibody production.
Abstract
Antibodies are powerful and versatile tools to play a critical role in the diagnosis and treatment of many diseases. Their application has been enhanced significantly with the advanced recombinant DNA and heterologonous expression technologies, allowing to produce munotherapeutic proteins with improved biofunctional properties. However, with currently available technologies, mammalian cell-based therapeutic antibody production, as an alternative for production in humans and animals, is often not plentiful for passive immunotherapeutics in treatment of many diseases. Recently, plant expression systems for therapeutic antibodies have become well-established. Thus, plants have been considered to provide an attractive alternative production system for therapeutic antibodies, as plants have several advantages such as the lack of human pathogens, and low cost of upstream production and flexible scale-up of highly valuable recombinant glycoproteins. Recent advances in modification of posttranslational processing for human-like glycosylation in transgenic plants will make it possible that plant can become a suitable protein expression system over the animal cellbased current production system. This review will discuss recent advances in plant expression technology and issues for their application to therapeutic antibody production.
참고문헌 (45)
- Armour, KL, "Recombinant human IgG molecules lacking Fc-gamma Receptor I binding and monocyte triggering activities", Eur J Immunol, 29, pp.2613~2624 (1999)
- Ashford DA, "The β -1→2-D-xylose and α-1→3-L-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin", Eur J Biochem, 166, pp.311~320 (1987)
- Bakker H, "Galactose-extended glycans of antibodies produced by transgenic plants", Proc Natl Acad Sci USA, 통권 : 98, pp.2899~2904 (2001)
- Balen B, "Glycoproteomic survey of Mammillaria gracillis tissues grown in vitro", J Proteome Res, 5, pp.1658~1666 (2006)
- Breedveld FC, "Therapeutic monoclonal antibodies", Lancet, 355, pp.735~740 (2000)
- Brodzik R, "Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells", Proc Natl Acad Sci USA, 통권 : 103, pp.8804~8809 (2006)
- Cabanes-Macheteau M, "NGlycosylation of a mouse IgG expressed in transgenic tobacco plants", Glycobiology, 9, pp.365~372 (1999)
- Capon C, "Structural analysis of the carbohydrate chain isolated from jacalin lectin", Carbohydr Res, 199, pp.121~127 (1990)
- Conrad U, "Compartment-specific accumulation of recombinant immunoglobulins in plant cells:an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity", Plant Mol Biol, 38, pp.101~109 (1998)
- Conrad U, "High-level and stable accumulation of single-chain Fv antibodies in plant storage organs", J Plant Physiol, 152, pp.708~711 (1998)
- D’Andrea G, "Primary structure of the xylose-containing N-linked carbohydrate moiety from ascorbic acid oxidase of Cucurbita pepo medullosa", Glycoconj J, 5, pp.151~157 (1988)
- Daniell H, "Molecular strategies for gene containment in transgenic crops", Nat Biotechnol, 20, pp.581~586 (2002)
- De Wilde C, "Plants as bioreactors for protein production:avoiding the problem of transgene silencing", Plant Mol Biol, 43, pp.347~359 (2000)
- Doran P, "Foreign Protein Production in Plant Tissue Cultures", Current Opinion in Biotechnology, 11, pp.199~204 (2000)
- Faye L, "Structure, biosynthesis, and function of asparagine-linked glycans on plant glycoproteins", Physiologia Plantarum, 75, pp.309~314 (1989)
- Fitchette AC, "Distribution of xylosylation and fucosylation in the plant Golgi apparatus", Plant J, 5, pp.673~682 (1994)
- Fitchette AC, "N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells", Plant J, 12, pp.1411~1417 (1997)
- Fitchette AC, "Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell", Plant Physiol, 121, pp.333~344 (1999)
- Fraley RT, "Expression of bacterial genes in plant cells", Proc Natl Acad Sci USA, 통권 : 80, pp.4803~4807 (1983)
- Gomord W, "Biopharmaceutical production in plants:problems, solutions and opportunities", Trends in Biotechno, 23, pp.559~565 (2005)
- Horsch RB, "Inheritance of functional foreign genes in plants", Science, 223, pp.496~498 (1984)
- Jamal A, "Biological Validation of Plant-Derived Anti-Human Colorectal Cancer Monoclonal Antibody CO17-1A", Hybridoma, 28, pp.7~12 (2009)
- Jefferis R, "IgG-Fc-mediated effector functions:molecular definition of interaction sites for effector ligands and the role of glycosylation", Immunol Rev, 163, pp.50~76 (1998)
- Ko K, "Inhibition of tumor growth by plant-derived mAb", Proc Natl Acad Sci USA, 통권 : 102, pp.7026~7030 (2005)
- Ko K, "Plant biopharming of monoclonal antibodies", Virus Res, 111, pp.93~100 (2005)
- Ko K, "Function and glycosylation of plantderived antiviral monoclonal antibody", Proc Natl Acad Sci USA, 통권 : 100, pp.8013~8018 (2003)
- Kornfeld R, "Assembly of asparagine-linked oligosaccharides", Annu Rev Biochem, 54, pp.631~664 (1985)
- Kermode AR, "Mechanisms of intracellular protein transport and targeting in plant cells", Crit Rev Plant Sci, 15, pp.285~423 (1996)
- Koziel MG, "Optimizing expression of transgenes with an emphasis on post-transcriptional events", Plant Mol Biol, 32, pp.393~405 (1996)
- Kuby J, "Immunology. Third Edition", pp.664~ (1997), W. H. Freeman and Company
- Kusnadi, AR, "Production and purification of two recombinant proteins from transgenic corn", Biotechnol Progress, 14, pp.149~155 (1998)
- Lerouge P, "N-glycosylation biosynthesis in plants:recent developments and future trends", Plant Mol Biol, 38, pp.31~48 (1998)
- Ma JK, "Plant-derived pharmaceuticals-the road forward", Trends Plant Sci, 10, pp.580~585 (2005)
- Ma JK, "The production of recombinant pharmaceutical proteins in plants", Nat Rev Genet, 4, pp.794~805 (2003)
- Ma JK, "Generation and assembly of secretory antibodies in plants", Science, 268, pp.716~719 (1995)
- Ma JKC, "Plant expression systems for the production of vaccines", Curr Top Microbiol Immunol, 236, pp.275~292 (1999)
- Melo NS, "Identification of the human Lewis(a) carbohydrate motif in a secretory peroxidase from a plant cell suspension culture (Vaccinium myrtillus L.)", FEBS Lett, 415, pp.186~191 (1997)
- Miele L, "Plants as bioreactors for biopharmaceuticals:regulatory considerations", Trends Biotechnol, 15, pp.45~50 (1997)
- Pen J, "Comparison of host systems for the production of recombinant proteins. in: Transgenic plants:a production system for industrial and pharmaceutical proteins", pp.149~167 (1996), John Wiley and Sons Ltd
- Priem B, "Structure of ten free N-glycans in ripening tomato fruit", Plant Physiol, 102, pp.445~458 (1993)
- Ruf S, "Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit", Nat Biotechnol, 19, pp.870~875 (2001)
- Shah MM, "Sialylated endogenous glycoconjugates in plant cells", Nat Biotechnol, 21, pp.1470~1471 (2003)
- Shields RL, "High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R", J Biol Chem, 276, pp.6591~6604 (2001)
- Strasser R, "Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1, 3-linked fucose", FEBS Lett, 561, pp.132~136 (2004)
- Tekoah Y, "Controlled glycosylation of therapeutic antibodies in plants", Arch Biochem Biophys, 426, pp.266~278 (2004)